AOD-9604 is a modified peptide fragment of human growth hormone (hGH), specifically the C-terminal region (176-191). It is designed to promote lipolysis (fat breakdown) without the anabolic or insulin-increasing effects of full-length hGH. AOD-9604 has been studied for its role in fat loss, cartilage regeneration, and metabolic health.

Research Focus:

• Fat loss and lipolysis
• Obesity and metabolic disorders
• Preservation of lean muscle mass during fat loss
• Metabolic health applications without IGF-1 elevation

Sources:

hGH 176-191 lipolysis fragment (Endocrinology): https://academic.oup.com/endo/article-abstract/128/5/2280/2652622

Clinical safety of AOD-9604 (Drug Design, Development and Therapy): https://www.dovepress.com/the-safety-and-tolerability-of-aod9604-in-human-clinical-trials-peer-reviewed-article-DDDT

GH fragments & fat metabolism review (Endocrinology & Metabolism Clinics): https://www.endocrinology.theclinics.com/article/S0889-8529(06)00022-7/fulltext

⚠️ Disclaimer: For research use only. Not intended for human consumption. This information is provided for educational purposes and has not been evaluated by the FDA.